EIF1AX

EIF1AX (historically eIF-4C/eIF-1A) is a eukaryotic translation initiation factor that acts catalytically to transfer the initiator Met-tRNAf (as the Met-tRNAf·eIF2·GTP ternary complex) to 40S ribosomal subunits, forming the 40S preinitiation complex without itself remaining stably associated with the assembled complex (PMID:9065455). It functions accessory to eIF-3 in dissociating native 80S ribosomes into subunits, preventing premature 40S–60S association, and resolving inactive 40S dimers into active monomers (PMID:6901506), and it is an RNA-binding protein whose basic N-terminus/acidic C-terminus dipole architecture is conserved across species and mediates ribosome and factor contacts (PMID:8106356, PMID:7890705). Beyond its core initiation role, EIF1AX drives proliferation: its overexpression promotes protein synthesis and cell growth (PMID:25281768), and it accelerates G1/S transition through p53-independent transcriptional repression of p21/CDKN1A (PMID:32926483). Cancer-associated mutations cluster regionally — N-terminal missense changes recur in uveal melanoma and co-occur with NRAS in low-grade serous ovarian carcinoma to promote proliferation (PMID:23793026, PMID:28646021), while the C-terminal A113splice variant stabilizes the 43S preinitiation complex and induces ATF4 to suppress eIF2α phosphorylation, globally elevating protein synthesis and cooperating with RAS/c-MYC to sensitize mTOR to amino acid supply (PMID:30305285). In endometrial carcinoma, XPO1-mediated cytoplasmic localization of EIF1AX promotes migration, invasion, and EMT, whereas forced nuclear import suppresses these phenotypes (PMID:36589683).

1. 1980 Medium

   Established that EIF1AX (eIF-4C) acts at the ribosome-dissociation step of initiation rather than as a passive cofactor, defining its role in generating and maintaining the active 40S subunit pool.

   Evidence In vitro ribosome dissociation and initiation complex formation with native/washed subunits

   PMID:6901506

   Open questions at the time

   • Single lab, not independently replicated in this corpus
   • Structural basis of anti-association activity not defined
2. 1993 Medium

   Distinguished EIF1AX function from mRNA-binding initiation factors by showing the wheat germ ortholog acts as a single polypeptide with no mRNA-specific concentration requirement, ruling out a direct role in mRNA recruitment.

   Evidence Purification and in vitro translation with multiple mRNA species (plant ortholog)

   PMID:8227048

   Open questions at the time

   • Plant ortholog model
   • Negative finding for mRNA binding role
3. 1994 Medium

   Defined the conserved basic-N-terminus/acidic-C-terminus dipole architecture and demonstrated functional interchangeability across species, framing the structural basis for ribosome and factor interactions.

   Evidence Peptide sequencing, cDNA cloning, heterologous in vitro translation

   PMID:8106356

   Open questions at the time

   • No high-resolution structure
   • Specific rRNA/factor contacts not mapped
4. 1995 Medium

   Characterized EIF1AX as an RNA-binding protein present at sub-stoichiometric levels relative to ribosomes and showed it is not rate-limiting for translation, refining its catalytic (not stoichiometric) role.

   Evidence Northwestern blotting, abundance quantification, overexpression in COS-1 cells

   PMID:7890705

   Open questions at the time

   • RNA targets not defined
   • Overexpression negative result in normal cells contrasts with later cancer findings
5. 1996 Medium

   Linked EIF1AX expression to early developmental gene activation, showing its mRNA is transiently induced at zygotic gene activation in a DNA-replication- and chromatin-remodeling-dependent manner.

   Evidence Differential display, RT-PCR, pharmacological perturbation in mouse embryos

   PMID:8631492

   Open questions at the time

   • Functional consequence of induction unclear
   • Mouse embryo-specific context
6. 1997 High

   Resolved the catalytic mechanism: EIF1AX promotes Met-tRNAf ternary complex transfer to 40S subunits but is absent from the resulting complex, showing it acts catalytically and not by stabilizing tRNA binding.

   Evidence In vitro reconstitution with purified mammalian factors and eIF5-dependent 80S formation

   PMID:9065455

   Open questions at the time

   • Kinetic mechanism of release not detailed
   • No structural snapshot of the catalytic intermediate
7. 2013 Medium

   Identified EIF1AX as a recurrently mutated cancer gene, with in-frame N-terminal mutations clustering in disomy-3 uveal melanoma and mutual exclusivity with SF3B1, implicating the initiation-fidelity region in tumorigenesis.

   Evidence Exome and targeted resequencing of uveal melanoma cohorts

   PMID:23793026

   Open questions at the time

   • No direct functional mechanism for N-terminal mutations
   • Effect on initiation fidelity not assayed
8. 2014 Medium

   Placed EIF1AX in a physical interaction network with 14-3-3γ and RPS7 coupling it to translation and proliferation control beyond the canonical PIC.

   Evidence Co-IP, MALDI-TOF/TOF MS, FRET, colocalization, overexpression (bovine cells)

   PMID:25281768

   Open questions at the time

   • Bovine cell model
   • Functional role of 14-3-3γ binding not dissected
9. 2017 Medium

   Provided functional evidence that N-terminal EIF1AX mutants cooperate oncogenically with NRAS, showing co-occurrence and joint promotion of proliferation in ovarian carcinoma.

   Evidence Sequencing plus coexpression and clonogenic assays in LGSC cell lines

   PMID:28646021

   Open questions at the time

   • Molecular basis of NRAS cooperation not resolved
   • Single lab
10. 2018 High

    Delineated the oncogenic mechanism of the C-terminal A113splice variant: PIC stabilization induces ATF4, suppresses eIF2α phosphorylation, raises global translation, and cooperates with RAS/c-MYC to drive mTOR amino-acid sensitization.

    Evidence Isogenic cell lines, mouse tumorigenesis, PIC/phosphorylation assays, inhibitor studies

    PMID:30305285

    Open questions at the time

    • Whether N-terminal mutants share this PIC-stabilizing mechanism unknown
    • Direct biophysical basis of PIC stabilization not shown
11. 2020 Medium

    Identified a transcriptional, translation-independent oncogenic activity: EIF1AX represses p21/CDKN1A in a p53-independent manner to drive G1/S progression.

    Evidence ChIP, luciferase reporter, RNA-Seq, flow cytometry, xenograft with shRNA knockdown

    PMID:32926483

    Open questions at the time

    • Mechanism of nuclear/chromatin recruitment to CDKN1A unclear
    • Relationship to canonical cytoplasmic initiation role unresolved
12. 2022 Medium

    Showed that subcellular localization governs EIF1AX oncogenic output, with XPO1-mediated cytoplasmic localization driving migration/invasion/EMT and nuclear import suppressing them in endometrial carcinoma.

    Evidence shRNA, SV40NLS forced import, leptomycin B, NES mutagenesis, migration/metastasis assays

    PMID:36589683

    Open questions at the time

    • Molecular effectors downstream of cytoplasmic localization not fully defined
    • Single lab
13. 2022 Low

    Proposed a feed-forward loop in which EIF1AX regulates its own mRNA via PCBP1 and promotes c-Myc IRES-dependent translation through YBX-1 to sustain proliferation.

    Evidence RIP, Co-IP, proliferation/apoptosis assays (findings secondary to an lncRNA study)

    PMID:35080085

    Open questions at the time

    • Mechanistic findings are secondary results in an lncRNA-focused paper
    • YBX-1 interaction and IRES activity not independently confirmed
14. 2025 Medium

    Revealed a nucleolar, senescence-inducing function whereby drug-triggered EIF1AX translocation recruits DDX21 into nucleolar aggregates that suppress rDNA transcription.

    Evidence Compound/CRISPR screens, co-IP MS, CUT&TAG, in vivo tumor assays

    PMID:41405406

    Open questions at the time

    • Endogenous trigger of nucleolar translocation unknown
    • Structural basis of DDX21 aggregate formation not defined

• How EIF1AX's canonical cytoplasmic translation-initiation activity mechanistically connects to its nuclear/nucleolar transcriptional and senescence functions remains unresolved.
• No unified model linking initiation activity to chromatin/rDNA regulation
• N-terminal vs C-terminal mutation mechanisms not reconciled
• Structural basis of mutation-driven PIC stabilization absent